Brief: Positive Data Presented At Hfsa Annual Meeting Demonstrate Effects Of Oral Levosimendan In Patients With Pulmonary Hypertension And Heart Failure With Preserved Ejection Fraction (Ph-Hfpef)
10/10/2022 13:31
Oct 10 (Reuters) - Tenax Therapeutics Inc TENX.O :
* POSITIVE DATA PRESENTED AT HFSA ANNUAL MEETING DEMONSTRATE
EFFECTS OF ORAL LEVOSIMENDAN IN PATIENTS WITH PULMONARY
HYPERTENSION AND HEART FAILURE WITH PRESERVED EJECTION FRACTION
(PH-HFPEF)
Source text for Eikon: ID:nGNX240ZKg
Further company coverage: TENX.O
((Reuters.Briefs@thomsonreuters.com;))